1. Drug interaction warning extends to astemizole

   Comment 08 February 2013 Pages: 2 - 2

2. Naproxen 500mg 12-hourly did not affect the pharmacokinetics of zidovudine

   Clinical study 08 February 2013 Pages: 2 - 2

3. Gold(III)-reactive T lymphocytes were found in patients with sodium aurothiomalate (gold-(I))-induced dermatitis,

   Clinical study 08 February 2013 Pages: 3 - 3

4. More action needed to inform patients of lithium risks

   Clinical study 08 February 2013 Pages: 3 - 3

5. Moxonidine – a more tolerable centrally acting antihypertensive

   Review 08 February 2013 Pages: 3 - 3

6. Perceived benefits of antiasthmatics outweigh adverse effects

   Incidence study 08 February 2013 Pages: 3 - 3

7. Amfebutamone no safer in bipolar depression

   Clinical study 08 February 2013 Pages: 4 - 4

8. Amineptine

   Case report 08 February 2013 Pages: 4 - 4

9. Amphetamine abuse

   Case report 08 February 2013 Pages: 4 - 4

10. Calcium antagonists may not be the answer for opiate withdrawal

    Case reports 08 February 2013 Pages: 4 - 4

11. Amphotericin B/colistin/tobramycin

    Incidence study 08 February 2013 Pages: 5 - 5

12. Antineoplastics

    Case report 08 February 2013 Pages: 5 - 5

13. Antipsychotics

    Case report 08 February 2013 Pages: 5 - 5

14. Asparaginase

    Incidence study 08 February 2013 Pages: 5 - 5

15. Auranofin

    Case report 08 February 2013 Pages: 5 - 5

16. Bupivacaine

    Case report 08 February 2013 Pages: 5 - 5

17. Cefotetan

    Case report 08 February 2013 Pages: 5 - 5

18. Cisplatin

    Incidence study 08 February 2013 Pages: 5 - 5

19. Clomipramine

    Case report 08 February 2013 Pages: 6 - 6

20. Clozapine interaction

    Case reports 08 February 2013 Pages: 6 - 6

21. Colchicine

    Case report 08 February 2013 Pages: 6 - 6

22. Cyclosporin

    Incidence study 08 February 2013 Pages: 6 - 6

23. Deferoxamine

    Case report 08 February 2013 Pages: 6 - 6

24. Dextrose

    Case report 08 February 2013 Pages: 6 - 6

25. Diclofenac

    Case report 08 February 2013 Pages: 7 - 7

26. Digoxin interaction

    Case report 08 February 2013 Pages: 7 - 7

27. Gemfibrozil

    Case report 08 February 2013 Pages: 7 - 7

28. Gonadotrophin

    Case report 08 February 2013 Pages: 7 - 7

29. Goserelin

    Clinical study 08 February 2013 Pages: 7 - 7

30. Hepatitis B vaccine

    Case report 08 February 2013 Pages: 8 - 8

31. Imipenem/cilastatin

    Case report 08 February 2013 Pages: 8 - 8

32. Interferon alpha

    Case report 08 February 2013 Pages: 8 - 8

33. Isoniazid

    Case report 08 February 2013 Pages: 8 - 8

34. Lidocaine

    Case report 08 February 2013 Pages: 8 - 8

35. Lithium

    Case report 08 February 2013 Pages: 8 - 8

36. Methotrexate

    Incidence study 08 February 2013 Pages: 8 - 8

37. Methylphenidate

    Case reports 08 February 2013 Pages: 10 - 10

38. Metoclopramide

    Case report 08 February 2013 Pages: 10 - 10

39. Mitomycin

    Case report 08 February 2013 Pages: 10 - 10

40. Moracizine

    Case report 08 February 2013 Pages: 10 - 10

41. Muromonab CD3

    Case report 08 February 2013 Pages: 10 - 10

42. Nilvadipine/nifedipine

    Incidence study 08 February 2013 Pages: 10 - 10

43. Ondansetron

    Case report 08 February 2013 Pages: 11 - 11

44. Paracetamol overdose

    Case report 08 February 2013 Pages: 11 - 11

45. Phenytoin

    Incidence study 08 February 2013 Pages: 11 - 11

46. Pneumococcal vaccine

    Case report 08 February 2013 Pages: 11 - 11

47. Psoralens + ultraviolet A light

    Case reports 08 February 2013 Pages: 11 - 11

48. Rifampicin

    Case report 08 February 2013 Pages: 11 - 11

49. Roxithromycin

    Case report 08 February 2013 Pages: 11 - 11

50. Salbutamol overdose

    Case report 08 February 2013 Pages: 12 - 12